

[ Mon, Oct 07th 2024
] - WOPRAI

[ Wed, Oct 02nd 2024
] - WOPRAI

[ Mon, Aug 12th 2024
] - WOPRAI

[ Wed, May 15th 2024
] - WOPRAI

[ Thu, May 02nd 2024
] - WOPRAI

[ Thu, Mar 07th 2024
] - WOPRAI

[ Wed, Nov 08th 2023
] - WOPRAI

[ Thu, Nov 02nd 2023
] - WOPRAI

[ Fri, Aug 04th 2023
] - WOPRAI

[ Thu, Jul 27th 2023
] - WOPRAI

[ Fri, Jul 14th 2023
] - WOPRAI

[ Fri, Jun 02nd 2023
] - WOPRAI

[ Thu, May 11th 2023
] - WOPRAI

[ Mon, Apr 17th 2023
] - WOPRAI

[ Tue, Mar 07th 2023
] - WOPRAI

[ Fri, Mar 03rd 2023
] - WOPRAI

[ Tue, Feb 28th 2023
] - WOPRAI

[ Fri, Dec 16th 2022
] - WOPRAI

[ Tue, Dec 13th 2022
] - WOPRAI

[ Thu, Aug 18th 2022
] - WOPRAI

[ Fri, Jul 01st 2022
] - WOPRAI

[ Thu, May 26th 2022
] - WOPRAI

[ Wed, May 11th 2022
] - WOPRAI

[ Wed, Apr 13th 2022
] - WOPRAI

[ Tue, Jan 18th 2022
] - WOPRAI

[ Tue, Oct 26th 2021
] - WOPRAI

[ Fri, Oct 15th 2021
] - WOPRAI

[ Tue, Jul 27th 2021
] - WOPRAI

[ Tue, Jun 01st 2021
] - WOPRAI

[ Mon, May 10th 2021
] - WOPRAI

[ Tue, Apr 20th 2021
] - WOPRAI

[ Tue, Jan 26th 2021
] - WOPRAI

[ Tue, Jan 05th 2021
] - WOPRAI
[ Tue, Jan 05th 2021
] - WOPRAI

[ Thu, Oct 08th 2020
] - WOPRAI
[ Thu, Oct 08th 2020
] - WOPRAI

[ Fri, Aug 28th 2020
] - WOPRAI

[ Thu, Apr 16th 2020
] - WOPRAI


[ Wed, Oct 17th 2018
] - WOPRAI

[ Tue, Sep 18th 2018
] - WOPRAI

[ Wed, Oct 25th 2017
] - WOPRAI

[ Wed, Oct 18th 2017
] - WOPRAI

[ Fri, Jul 14th 2017
] - WOPRAI

[ Wed, Nov 09th 2016
] - WOPRAI
[ Wed, Nov 09th 2016
] - WOPRAI

[ Tue, Nov 18th 2014
] - WOPRAI

[ Fri, Feb 21st 2014
] - WOPRAI

[ Mon, Dec 16th 2013
] - WOPRAI
[ Mon, Dec 16th 2013
] - WOPRAI

[ Fri, Apr 05th 2013
] - WOPRAI

[ Fri, Jan 11th 2013
] - WOPRAI

[ Thu, Oct 11th 2012
] - WOPRAI

[ Mon, Oct 01st 2012
] - WOPRAI

[ Fri, Apr 20th 2012
] - WOPRAI

[ Thu, Apr 05th 2012
] - WOPRAI

[ Mon, Mar 19th 2012
] - WOPRAI
Kevin Fischbeck Downgraded (AMN) to Sell and Decreased Target to $48 on, Oct 7th, 2024
Kevin Fischbeck of B of A Securities, Downgraded "AMN Healthcare Services, Inc." (AMN) to Sell and Decreased Target from $65 to $48 on, Oct 7th, 2024.
Kevin has made no other calls on AMN in the last 4 months.
There are 4 other peers that have a rating on AMN. Out of the 4 peers that are also analyzing AMN, 2 agree with Kevin's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Bill Sutherland of "Benchmark" Reiterated at Hold on, Wednesday, October 2nd, 2024
- A.J. Rice of "UBS" Maintained at Hold with Decreased Target to $65 on, Friday, August 9th, 2024
These are the ratings of the 2 analyists that currently disagree with Kevin
- Constantine Davides of "JMP Securities" Reiterated at Buy and Held Target at $66 on, Friday, October 4th, 2024
- Jeffrey Silber of "BMO Capital" Maintained at Buy with Increased Target to $71 on, Monday, August 12th, 2024